Open AccessUse and cardiovascular safety of transdermal and other granisetron preparations in cancer management
Author(s) -
Jay W. Mason,
Moon
Publication year - 2013
Publication title -
cancer management and research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.024
H-Index - 40
ISSN - 1179-1322
DOI - 10.2147/cmar.s34352
Subject(s) - granisetron , transdermal , medicine , nausea , vomiting , palonosetron , anesthesia , pharmacology , intensive care medicine , antiemetic
5-HT3 antagonists have been available as oral and intravenous preparations for decades. The availability more recently of transdermal granisetron and the anticipated availability of a subcutaneous granisetron preparation have provided helpful alternatives to patients, and these preparations have been shown to have less potential to prolong QT than other drugs in the class.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom